# Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency

> **NCT00771446** · PHASE1,PHASE2 · COMPLETED · sponsor: **Vital Therapies, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Acute Hepatitis
- Chronic Hepatitis

## Interventions

- **BIOLOGICAL:** ELAD plus standard of care treatment
- **OTHER:** Standard of care treatment

## Key facts

- **NCT ID:** NCT00771446
- **Lead sponsor:** Vital Therapies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2013-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771446, "Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00771446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*